Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

Losing your sense of direction is one of the earliest and most distressing signs of advanced Alzheimer's disease. Now, a new ...

Britons are now vaping in unprecedented numbers - around one in ten adults (9.8 per cent) in 2023, rising to 15.8 per cent ...